Levy G, Guglielmelli P, Langmuir P, et al. JAK inhibitors and COVID-19. J Immunother Cancer 2022;10:e002838. doi:10.1136/jitc-2021-002838
The author Stefan Constantinescu has been updated to Stefan N Constantinescu.
. 2023 Apr 28;11(4):e002838corr1. doi: 10.1136/jitc-2021-002838corr1
Correction: JAK inhibitors and COVID-19
Collection date 2023.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.
PMCID: PMC10152002 PMID: 37117008
This corrects the article "JAK inhibitors and COVID-19" in volume 10, e002838.